| pubmed-article:1471918 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1471918 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:1471918 | lifeskim:mentions | umls-concept:C0751674 | lld:lifeskim |
| pubmed-article:1471918 | lifeskim:mentions | umls-concept:C0029936 | lld:lifeskim |
| pubmed-article:1471918 | lifeskim:mentions | umls-concept:C1334080 | lld:lifeskim |
| pubmed-article:1471918 | lifeskim:mentions | umls-concept:C0085973 | lld:lifeskim |
| pubmed-article:1471918 | lifeskim:mentions | umls-concept:C0007320 | lld:lifeskim |
| pubmed-article:1471918 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1471918 | pubmed:dateCreated | 1993-1-27 | lld:pubmed |
| pubmed-article:1471918 | pubmed:abstractText | The gender-specific prevalence of lymphangioleiomyomatosis (LAM) in premenopausal women suggests a hormonal etiology. Despite the antiestrogenic treatment (ovariectomy, tamoxifen) this disease is often refractory to therapy and almost inevitably leads to the patient's death. We describe a case where the antiproliferative effect of systemically applied interferon alpha 2b was successfully employed in addition to ovariectomy and the patient reached complete remission. | lld:pubmed |
| pubmed-article:1471918 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1471918 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1471918 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1471918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1471918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1471918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1471918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1471918 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1471918 | pubmed:issn | 0932-0067 | lld:pubmed |
| pubmed-article:1471918 | pubmed:author | pubmed-author:KleinMM | lld:pubmed |
| pubmed-article:1471918 | pubmed:author | pubmed-author:RosenAA | lld:pubmed |
| pubmed-article:1471918 | pubmed:author | pubmed-author:BeckAA | lld:pubmed |
| pubmed-article:1471918 | pubmed:author | pubmed-author:WaldnerRR | lld:pubmed |
| pubmed-article:1471918 | pubmed:author | pubmed-author:KriegerOO | lld:pubmed |
| pubmed-article:1471918 | pubmed:author | pubmed-author:PreisPP | lld:pubmed |
| pubmed-article:1471918 | pubmed:author | pubmed-author:RuckserRR | lld:pubmed |
| pubmed-article:1471918 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1471918 | pubmed:volume | 252 | lld:pubmed |
| pubmed-article:1471918 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1471918 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1471918 | pubmed:pagination | 99-102 | lld:pubmed |
| pubmed-article:1471918 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:meshHeading | pubmed-meshheading:1471918-... | lld:pubmed |
| pubmed-article:1471918 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1471918 | pubmed:articleTitle | Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report. | lld:pubmed |
| pubmed-article:1471918 | pubmed:affiliation | Department of Gynecology and Obstetrics, Hanusch-Krankenhaus, Vienna, Austria. | lld:pubmed |
| pubmed-article:1471918 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1471918 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1471918 | lld:pubmed |
